4 weeks TransMedics Group (NASDAQ:TMDX) Price Target Lowered to $109.00 at Needham & Company LLCMarketBeat
Needham & Company LLC cut their price target on TransMedics Group from $208.00 to $109.00 and set a “buy” rating for the company in a research note on Tuesday.
X